{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:49:57Z","timestamp":1792792197971,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T00:00:00Z","timestamp":1550534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12888-019-2055-1","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T10:08:09Z","timestamp":1550570889000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["A case report of\u00a0cholinergic rebound syndrome following abrupt low-dose clozapine discontinuation in a patient with type I bipolar affective disorder"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0424-7265","authenticated-orcid":false,"given":"Andrea","family":"Galova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Berney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules","family":"Desmeules","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Sergentanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Besson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,19]]},"reference":[{"key":"2055_CR1","unstructured":"Katzung BG MS, Trevor A (Ed.): Basic and Clinical Pharmacology 12th edition: McGraw-Hill Medical; 2012."},{"issue":"Suppl 2","key":"2055_CR2","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/S0924-9338(10)71701-6","volume":"25","author":"CU Correll","year":"2010","unstructured":"Correll CU. From receptor pharmacology to improved outcomes: individualising the selection, dosing and switching of antipsychotics. Eur Psychiatry. 2010;25(Suppl 2):S12\u201321.","journal-title":"Eur Psychiatry"},{"key":"2055_CR3","unstructured":"Stahl MS. Stahl's essential psychopharmacology: Neuroscientific basis and practical applications: Cambridge University Press; 2008."},{"issue":"2","key":"2055_CR4","first-page":"122","volume":"36","author":"R Durst","year":"1999","unstructured":"Durst R, Teitelbaum A, Katz G, Knobler HY. Withdrawal from clozapine: the \"rebound phenomenon\". Isr J Psychiatry Relat Sci. 1999;36(2):122\u20138.","journal-title":"Isr J Psychiatry Relat Sci"},{"issue":"2","key":"2055_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0006-3223(95)00215-4","volume":"39","author":"C Verghese","year":"1996","unstructured":"Verghese C, DeLeon J, Nair C, Simpson GM. Clozapine withdrawal effects and receptor profiles of typical and atypical neuroleptics. Biol Psychiatry. 1996;39(2):135\u20138.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"2055_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/BF00571412","volume":"56","author":"GM Simpson","year":"1978","unstructured":"Simpson GM, Lee JH, Shrivastava RK. Clozapine in tardive dyskinesia. Psychopharmacology. 1978;56(1):75\u201380.","journal-title":"Psychopharmacology"},{"issue":"3","key":"2055_CR7","first-page":"119","volume":"55","author":"J Leon de","year":"1994","unstructured":"de Leon J, Stanilla JK, White AO, Simpson GM. Anticholinergics to treat clozapine withdrawal. J Clin Psychiatry. 1994;55(3):119\u201320.","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"2055_CR8","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/schbul\/22.4.591","volume":"22","author":"TM Shiovitz","year":"1996","unstructured":"Shiovitz TM, Welke TL, Tigel PD, Anand R, Hartman RD, Sramek JJ, Kurtz NM, Cutler NR. Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal. Schizophr Bull. 1996;22(4):591\u20135.","journal-title":"Schizophr Bull"},{"issue":"6","key":"2055_CR9","doi-asserted-by":"publisher","first-page":"252","DOI":"10.4088\/JCP.v58n0603","volume":"58","author":"JK Stanilla","year":"1997","unstructured":"Stanilla JK, de Leon J, Simpson GM. Clozapine withdrawal resulting in delirium with psychosis: a report of three cases. J Clin Psychiatry. 1997;58(6):252\u20135.","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"2055_CR10","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/00004714-199910000-00007","volume":"19","author":"GD Tollefson","year":"1999","unstructured":"Tollefson GD, Dellva MA, Mattler CA, Kane JM, Wirshing DA, Kinon BJ. Controlled, double-blind investigation of the clozapine discontinuation symptoms with conversion to either olanzapine or placebo. The Collaborative Crossover Study Group. J Clin Psychopharmacol. 1999;19(5):435\u201343.","journal-title":"J Clin Psychopharmacol"},{"issue":"5","key":"2055_CR11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/01.wnf.0000145506.99636.1b","volume":"27","author":"AW Yeh","year":"2004","unstructured":"Yeh AW, Lee JW, Cheng TC, Wen JK, Chen WH. Clozapine withdrawal catatonia associated with cholinergic and serotonergic rebound hyperactivity: a case report. Clin Neuropharmacol. 2004;27(5):216\u20138.","journal-title":"Clin Neuropharmacol"},{"issue":"3","key":"2055_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3109\/10401239509149043","volume":"7","author":"S Gupta","year":"1995","unstructured":"Gupta S, Daniel DG. Cautions in the clozapine-to-risperidone switch. Ann Clin Psychiatry. 1995;7(3):149.","journal-title":"Ann Clin Psychiatry"},{"issue":"3","key":"2055_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1046\/j.1365-2710.1999.00218.x","volume":"24","author":"N Delassus-Guenault","year":"1999","unstructured":"Delassus-Guenault N, Jegouzo A, Odou P, Seguret T, Zangerlin H, Vignole E, Robert H. Clozapine-olanzapine: a potentially dangerous switch. A report of two cases. J Clin Pharm Ther. 1999;24(3):191\u20135.","journal-title":"J Clin Pharm Ther"},{"issue":"1\u20133","key":"2055_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.schres.2006.07.011","volume":"88","author":"ML Chew","year":"2006","unstructured":"Chew ML, Mulsant BH, Pollock BG, Lehman ME, Greenspan A, Kirshner MA, Bies RR, Kapur S, Gharabawi G. A model of anticholinergic activity of atypical antipsychotic medications. Schizophr Res. 2006;88(1\u20133):63\u201372.","journal-title":"Schizophr Res"},{"issue":"1\u201302","key":"2055_CR15","first-page":"9","volume":"51","author":"C Hiemke","year":"2018","unstructured":"Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, et al. Consensus guidelines for therapeutic drug monitoring in Neuropsychopharmacology: update 2017. Pharmacopsychiatry. 2018;51(1\u201302):9\u201362.","journal-title":"Pharmacopsychiatry"},{"key":"2055_CR16","doi-asserted-by":"crossref","unstructured":"Bilbily J, McCollum B, de Leon J: Catatonia secondary to sudden clozapine withdrawal: a case with three repeated episodes and a literature review. Case Rep Psychiatry 2017, 2017:2402731.","DOI":"10.1155\/2017\/2402731"},{"key":"2055_CR17","volume":"2015","author":"T Shahrour","year":"2015","unstructured":"Shahrour T, Siddiq M, Ghalib S, Alsaadi T. Severe relapsing clozapine-withdrawal catatonia. Case Rep Psychiatry. 2015;2015:606853.","journal-title":"Case Rep Psychiatry"},{"issue":"6","key":"2055_CR18","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3109\/00048674.2011.564135","volume":"45","author":"S Kumar","year":"2011","unstructured":"Kumar S, Sur S, Singh A. Catatonia following abrupt stoppage of clozapine. Aust N Z J Psychiatry. 2011;45(6):499.","journal-title":"Aust N Z J Psychiatry"},{"issue":"3","key":"2055_CR19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.5455\/bcp.20120731051540","volume":"22","author":"C Cerit","year":"2012","unstructured":"Cerit C, Tuzun B, Akpinar E, Sahan E. Clozapine withdrawal catatonia refractory to ECT: a case report. Klinik Psikofarmakoloji B\u00fclteni-Bulletin of Clinical Psychopharmacology. 2012;22(3):275\u20137.","journal-title":"Klinik Psikofarmakoloji B\u00fclteni-Bulletin of Clinical Psychopharmacology"},{"issue":"3","key":"2055_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3109\/10401239709147792","volume":"9","author":"JW Lee","year":"1997","unstructured":"Lee JW, Robertson S. Clozapine withdrawal catatonia and neuroleptic malignant syndrome: a case report. Ann Clin Psychiatry. 1997;9(3):165\u20139.","journal-title":"Ann Clin Psychiatry"},{"key":"2055_CR21","doi-asserted-by":"crossref","unstructured":"Boazak M, Cotes RO, Potvin H, Decker AM, Schwartz AC. Catatonia due to clozapine withdrawal: a case report and synthesis of the literature. Psychosomatics. 2018.","DOI":"10.1016\/j.psym.2018.07.010"},{"key":"2055_CR22","unstructured":"Kapulsky L, Greiner MG, Daniels JE, Gordon-Elliott JS. Clozapine discontinuation and malignant catatonia: a case report. Psychosomatics. ."},{"issue":"1","key":"2055_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41398-018-0192-9","volume":"8","author":"M Lander","year":"2018","unstructured":"Lander M, Bastiampillai T, Sareen J. Review of withdrawal catatonia: what does this reveal about clozapine? Transl Psychiatry. 2018;8(1):139.","journal-title":"Transl Psychiatry"},{"issue":"3","key":"2055_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1755-5949.2010.00142.x","volume":"16","author":"DB Lester","year":"2010","unstructured":"Lester DB, Rogers TD, Blaha CD. Acetylcholine-dopamine interactions in the pathophysiology and treatment of CNS disorders. CNS Neurosci Ther. 2010;16(3):137\u201362.","journal-title":"CNS Neurosci Ther"},{"key":"2055_CR25","unstructured":"Aubry JM, Berney P, Besson M, Curtis. L (Eds.): Psychotropes d'usage courant: Edition Medecine et Hygiene; 2017."},{"issue":"4","key":"2055_CR26","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1177\/106002809603000407","volume":"30","author":"TA Cheslik","year":"1996","unstructured":"Cheslik TA, Erramouspe J. Extrapyramidal symptoms following accidental ingestion of risperidone in a child. Ann Pharmacother. 1996;30(4):360\u20133.","journal-title":"Ann Pharmacother"},{"key":"2055_CR27","doi-asserted-by":"crossref","unstructured":"Karaca S, Ozatalay E, Canan F. A case of risperidone overdose in a 4-year-old boy. Prim Care Companion CNS Disord. 2016;18(2).","DOI":"10.4088\/PCC.15l01855"},{"issue":"11","key":"2055_CR28","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1177\/0004867411432215","volume":"46","author":"MK Shields","year":"2012","unstructured":"Shields MK, Bastiampillai T, Mohan T. Managing clozapine discontinuation - acute and chronic maintenance strategies. Aust N Z J Psychiatry. 2012;46(11):1104\u20135.","journal-title":"Aust N Z J Psychiatry"},{"key":"2055_CR29","volume":"2017","author":"A Modak","year":"2017","unstructured":"Modak A, Ahlin A. The treatment of clozapine-withdrawal delirium with electroconvulsive therapy. Case Rep Psychiatry. 2017;2017:1783545.","journal-title":"Case Rep Psychiatry"},{"issue":"5","key":"2055_CR30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.7453\/gahmj.2013.008","volume":"2","author":"JJ Gagnier","year":"2013","unstructured":"Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D. The CARE guidelines: consensus-based clinical case reporting guideline development. Glob Adv Health Med. 2013;2(5):38\u201343.","journal-title":"Glob Adv Health Med"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-019-2055-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12888-019-2055-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-019-2055-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T19:12:09Z","timestamp":1582053129000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-019-2055-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,19]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2055"],"URL":"https:\/\/doi.org\/10.1186\/s12888-019-2055-1","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,19]]},"assertion":[{"value":"3 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The written consent to submit this case report for review and publication by the journal was obtained from the patient.The manuscript has been written according to the CARE guidelines [].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"73"}}